OPDIVO VEA Trademark

Trademark Overview

On Friday, October 18, 2019, a trademark application was filed for OPDIVO VEA with the United States Patent and Trademark Office. The USPTO has given the OPDIVO VEA trademark a serial number of 88659964. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2023. This trademark is owned by Bristol-Myers Squibb Company. The OPDIVO VEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of cancer
opdivo vea

General Information

Serial Number88659964
Word MarkOPDIVO VEA
Filing DateFriday, October 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 4, 2023SOU EXTENSION 5 GRANTED
Friday, April 28, 2023SOU EXTENSION 5 FILED
Thursday, May 4, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022SOU EXTENSION 4 GRANTED
Wednesday, November 2, 2022SOU EXTENSION 4 FILED
Wednesday, November 2, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2022SOU EXTENSION 3 GRANTED
Monday, May 9, 2022SOU EXTENSION 3 FILED
Monday, May 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 20, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 20, 2021SOU EXTENSION 2 FILED
Wednesday, October 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 23, 2021SOU EXTENSION 1 GRANTED
Friday, April 23, 2021SOU EXTENSION 1 FILED
Friday, April 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 29, 2020NON-FINAL ACTION E-MAILED
Wednesday, January 29, 2020NON-FINAL ACTION WRITTEN
Friday, January 24, 2020ASSIGNED TO EXAMINER
Tuesday, October 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

opdivo prevention cancer treatment human preparations pharmaceutical